Financing Outlook for Florida Life Science and High Tech Companies: An Investor's Point of View
April 18, 2008
You have created a valuable intellectual property asset and assembled a core management team, and now it’s time to secure funding. In this session, a select group of investors and investment bankers in the high-tech and life sciences arena will tell you how they examine and analyze investment opportunities in this space. This discussion will focus on:
- Capital availability for Florida high-tech and life sciences companies (including impact of credit crunch)
- Areas of investor focus
- Lessons from recent deals
- Exit strategies
Related Insights
July 17, 2025
Foley Viewpoints
Tricky Compliance Issues for Companies When an Executive Terminates Employment: Stock Options, Restricted Stock, and Other Equity Incentive Awards
Executive employment relationships are rarely permanent. When an executive or other senior-level employee terminates employment,…
July 17, 2025
Health Care Law Today
One Big Beautiful Bill: Slashed Budgets Will Disrupt the Medicaid Program
The new federal budget law, the One Big Beautiful Bill Act (the Act), enacted on July 4, 2025, makes dramatic changes to the Medicaid…
July 16, 2025
Foley Viewpoints
Changes to the College and University Endowment Tax
The One Big Beautiful Bill Act (OBBBA) modifies the excise tax on net investment income of private colleges and universities under…